SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-10-001345
Filing Date
2010-11-12
Accepted
2010-11-12 16:58:01
Documents
7
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K cardiome6k.htm 6-K 19776
2 THIRD QUARTER REPORT FOR THE PERIOD ENDED SEPTEMBER 30, 2010 ex991.htm EX-99.1 1861198
3 CANADIAN SUPPLEMENT TO THE MDA FOR THE PERIOD ENDED SEPTEMBER 30, 2010 ex992.htm EX-99.2 53619
4 CERTIFICATE OF FILING - CEO ex993.htm EX-99.3 14210
5 CERTIFICATE OF FILING - CFO ex994.htm EX-99.4 14188
6 MATERIAL CHANGE REPORT ex995.htm EX-99.5 33229
7 LOGO cardiome.jpg GRAPHIC 12193
  Complete submission text file 0001279569-10-001345.txt   2014711
Mailing Address 6TH FLOOR 6190 AGRONOMY RD. VANCOUVER A1 V6T 1Z3
Business Address 6TH FLOOR 6190 AGRONOMY RD. VANCOUVER A1 V6T 1Z3 1-604-677-6905
Cardiome Pharma Corp (Filer) CIK: 0001036141 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-29338 | Film No.: 101187590
SIC: 2834 Pharmaceutical Preparations